Kymera Therapeutics, Inc. (KYMR)

NASDAQ: KYMR · Real-Time Price · USD

87.40

+0.90 (1.04%)

At close: Feb 20, 2026, 4:00 PM EST

88.88

+1.48 (1.69%)

After-hours: Feb 20, 2026, 5:24 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceuticals	47.07M	78.59M	46.83M	72.83M	34.03M
Pharmaceuticals Growth	-40.11%	67.84%	-35.71%	114.00%	1059.99%
Total	47.07M	78.59M	46.83M	72.83M	34.03M
Total Growth	-40.11%	67.84%	-35.71%	114.00%	1059.99%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	47.07M	78.59M	46.83M	72.83M	34.03M
United States Growth	-40.11%	67.84%	-35.71%	114.00%	1059.99%
Total	47.07M	78.59M	46.83M	72.83M	34.03M
Total Growth	-40.11%	67.84%	-35.71%	114.00%	1059.99%

Source: S&P Global Market Intelligence.